Breaking News
Get 40% Off 0
🔎 See NVDA full ProTips for an instant risks or rewards Claim 40% OFF

Safely ride market's ups and downs with our AI-powered 'Top Value Stocks' strategy

Published Dec 07, 2023 15:18
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
EBAY
+0.48%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
EXPE
-0.99%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
UTHR
+2.34%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Novice investors often overlook the pivotal importance of having top-of-line value stocks in their portfolios when the market is thriving. However, when times get tough, they are the first ones to look for solid companies with strong, globally recognizable brands and exceptional financial metrics.

Sadly, oftentimes, that's already too late to find such gems at a reasonable price.

In fact, the importance of the value concept in the world of finance is so pivotal that, as Warren Buffett himself would argue, every good investment should be considered a "value" investment:

"Price is what you pay. Value is what you get."

To guarantee you will never miss the value boat again, our 'Top Value Stocks' strategy employs advanced AI models to identify up to 20 U.S.-listed stocks each month that are undervalued yet possess solid earnings and are primed for growth.

These companies are typically trading at prices lower than their perceived intrinsic value, presenting them as potentially significant bargains for investors.

Historical data shows that our strategy would have beaten the S&P 500 by 567% over the last decade while keeping a relatively low risk exposure, as seen in the chart below:strategy 4Source: InvestingPro ProPicks

Let's take a deeper look at three of the stocks highlighted within the strategy as of now, namely: United Therapeutics, eBay, and Expedia (NASDAQ:EXPE), which are covered below in detail.

InvestingPro users can see the full strategy - along with the other five ProPicks strategies - on our ProPicks gallery page.

Not yet a Pro user? Subscribe now for an up to 60% discount for limited time only as part of our Extended Cyber Monday Sale!Claim Your Discount Now!

*Readers of this article can enjoy an exclusive 10% discount on our annual Pro+ plan with coupon code Value1, and a similar discount of 10% on the bi-yearly Pro+ plan by using coupon code Value2 at checkout!

1. United Therapeutics (UTHR)

  • InvestingPro Health Label: Great
  • InvestingPro Fair Value: Undervalued (27.0% Upside)
  • Forward P/E Ratio: 12.6x
  • Dividend Yield: 0.0%

United Therapeutics (NASDAQ:UTHR), a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Shares are up 7.4% in the past month and down 13.4% year to date.

What do Wall Street analysts say?

According to analysts surveyed by InvestingPro, United Therapeutics is Fairly valued with 24.6% Upside.

Earlier this month, UBS initiated coverage on United Therapeutics with a Buy rating and a price target of $320, citing Tyvaso diversified growth ahead, Remodulin stabilizing. The firm commented:

UTHR stock has doubled in last 2 years, but we continue to see meaningful upside ahead. 1) UTHR's Tyvaso is a foundational therapy for Pulmonary Arterial Hypertension (PAH); Tyvaso's transition into newly launched dry powder inhaler (DPI) format & expansion into PH-Interstitial Lung Disease (PH-ILD) fuels growth.

Key recent news

In November, United Therapeutics reported Q3 earnings of $5.38 per share on revenue of $609.4 million. Analysts were looking for $5.15 earnings on revenue of $587.9M.

In October, United Therapeutics and Miromatrix Medical (NASDAQ:MIRO) announced a definitive agreement for United Therapeutics to acquire Miromatrix, a life sciences company focused on the development of bioengineered organs composed of human cells.

2. eBay (EBAY)

  • InvestingPro Health Label: Good
  • InvestingPro Fair Value: Undervalued (35.8% Upside)
  • Forward P/E Ratio: 8.0x
  • Dividend Yield: 2.4%

eBay (NASDAQ:EBAY) operates marketplace platforms that connect buyers and sellers in the United States and internationally.

Shares are up 8.4% in the past month and 2.9% year to date.

What do Wall Street analysts say?

According to analysts surveyed by InvestingPro, eBay is Fairly valued with 7.8% Upside.

Most recently, in October, Stifel initiated coverage on eBay with a Hold rating, writing:

"We believe EBAY is taking the right approach, with a focus on key categories (which outpace corporate-level GMV growth), but we need to see improvement in the buyer base (and Enthusiast Buyers) and evidence that GMV is poised to show accelerating growth to be more positive on shares."

Key recent news

In November, eBay reported Q3 earnings of $1.03 per share on revenue of $2.5 billion. Analysts were looking for $1.00 earnings on revenue of $2.5B.

3. Molina Healthcare (MOH)

  • InvestingPro Health Label: Great
  • InvestingPro Fair Value: Undervalued (31.4% Upside)
  • Forward P/E Ratio: 22.7x
  • Dividend Yield: 0.0%

Molina Healthcare (NYSE:MOH) provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.

Shares are up 7.6% in the past month and 9.8% year to date.

What do Wall Street analysts say?

According to analysts surveyed by InvestingPro, Molina Healthcare is Fairly valued with 0.8% Upside.

Most recently, in June, UBS analyst Kevin Caliendo initiated coverage on Molina Healthcare with a Neutral rating and a price target of $310.00.

Key recent news

In October, Molina Healthcare reported Q3 earnings of $5.05 per share on revenue of $8.55B. Analysts were looking for $4.88 earnings on revenue of $8.24B.

Subscribe now to see all the the picks and follow the 'Top Value Stocks' strategy!Claim Your Discount Now!

*Readers of this article can enjoy an exclusive 10% discount on our annual Pro+ plan with coupon code Value1, and a similar discount of 10% on the bi-yearly Pro+ plan by using coupon code Value2 at checkout!

Safely ride market's ups and downs with our AI-powered 'Top Value Stocks' strategy
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email